-
1
-
-
0031984981
-
Advances in the diagnosis and treatment of neuroblastoma
-
Katzenstein HM, Cohn SL. Advances in the diagnosis and treatment of neuroblastoma. Curr Opin Oncol 1998; 10: 43-51.
-
(1998)
Curr. Opin. Oncol.
, vol.10
, pp. 43-51
-
-
Katzenstein, H.M.1
Cohn, S.L.2
-
2
-
-
0015236227
-
Special pattern of widespread neuroblastoma with a favourable prognosis
-
D'Angio GJ, Evans AE, Koop CE. Special pattern of widespread neuroblastoma with a favourable prognosis. Lancet 1971; 1: 1046-9.
-
(1971)
Lancet
, vol.1
, pp. 1046-1049
-
-
D'Angio, G.J.1
Evans, A.E.2
Koop, C.E.3
-
3
-
-
0028997723
-
Molecular basis for heterogeneity in human neuroblastomas
-
Brodeur GM. Molecular basis for heterogeneity in human neuroblastomas. Eur J Cancer 1995; 4: 505-10.
-
(1995)
Eur. J. Cancer
, vol.4
, pp. 505-510
-
-
Brodeur, G.M.1
-
4
-
-
0042898524
-
Neuroblastoma
-
Sutow WW, Vietti TJ, Fernbach DJ, editors. St. Louis: The CV. Mosby Co
-
Fernbach DJ, Williams TE, Donaldson MH. Neuroblastoma. In: Sutow WW, Vietti TJ, Fernbach DJ, editors. Clinical pediatric oncology. St. Louis: The CV. Mosby Co;1977. p. 506-37.
-
(1977)
Clinical Pediatric Oncology
, pp. 506-537
-
-
Fernbach, D.J.1
Williams, T.E.2
Donaldson, M.H.3
-
5
-
-
0028102524
-
Why does stage 4s neuroblastoma regress spontaneously?
-
Pritchard J, Hickman JA. Why does stage 4s neuroblastoma regress spontaneously? Lancet 1994; 344: 869-70.
-
(1994)
Lancet
, vol.344
, pp. 869-870
-
-
Pritchard, J.1
Hickman, J.A.2
-
6
-
-
0032152769
-
Molecular basis of spontaneous regression of neuroblastoma: Role of neurotrophic signals and genetic abnormalities
-
Nakagawara A. Molecular basis of spontaneous regression of neuroblastoma: role of neurotrophic signals and genetic abnormalities. Hum Cell 1998; 3: 115-24.
-
(1998)
Hum. Cell
, vol.3
, pp. 115-124
-
-
Nakagawara, A.1
-
7
-
-
0030039499
-
In situ detection of DNA fragmentation and expression of bcl-2 in human neuroblastoma: Relation to apoptosis and spontaneous regression
-
Oue T, Fukuzawa M, Kusafuka T, Kohmoto Y, Imura K, Nagahara S, Okada A. In situ detection of DNA fragmentation and expression of bcl-2 in human neuroblastoma: relation to apoptosis and spontaneous regression. J Pediatr Surg 1996; 31: 251-7.
-
(1996)
J. Pediatr. Surg.
, vol.31
, pp. 251-257
-
-
Oue, T.1
Fukuzawa, M.2
Kusafuka, T.3
Kohmoto, Y.4
Imura, K.5
Nagahara, S.6
Okada, A.7
-
8
-
-
0030889550
-
Induction of apoptosis by p75 neurotropin receptor in human neuroblastoma cells
-
Burone G, Mariotti A, Compagni A, Morandi E, Della Valle G. Induction of apoptosis by p75 neurotropin receptor in human neuroblastoma cells. Oncogene 1997; 14: 1463-70.
-
(1997)
Oncogene
, vol.14
, pp. 1463-1470
-
-
Burone, G.1
Mariotti, A.2
Compagni, A.3
Morandi, E.4
Della Valle, G.5
-
9
-
-
0030752603
-
The CD95 (APO-1/Fas) system mediates drug-induced apoptosis in neuroblastoma cells
-
Fulda S, Sieverts H, Friesen C, Herr I, Debatin KM. The CD95 (APO-1/Fas) system mediates drug-induced apoptosis in neuroblastoma cells. Cancer Res 1997; 57: 3823-9.
-
(1997)
Cancer Res.
, vol.57
, pp. 3823-3829
-
-
Fulda, S.1
Sieverts, H.2
Friesen, C.3
Herr, I.4
Debatin, K.M.5
-
10
-
-
0028927607
-
The Fas death factor
-
Nagata S, Golstein P. The Fas death factor. Science 1995; 267: 1449-56.
-
(1995)
Science
, vol.267
, pp. 1449-1456
-
-
Nagata, S.1
Golstein, P.2
-
11
-
-
0033491193
-
CD95 (APO-1/Fas)-mediated apoptosis: Live and let die
-
Krammer PH. CD95 (APO-1/Fas)-mediated apoptosis: live and let die. Adv Immunol 1999; 71: 163-210.
-
(1999)
Adv. Immunol.
, vol.71
, pp. 163-210
-
-
Krammer, P.H.1
-
12
-
-
0029026548
-
FADD, a novel death domain-containing protein, interacts with the death domain of Fas and initiates apoptosis
-
Chinnaiyan AM, O'Rourke K, Tewari M, Dixit VM. FADD, a novel death domain-containing protein, interacts with the death domain of Fas and initiates apoptosis. Cell 1995; 81: 505-12.
-
(1995)
Cell
, vol.81
, pp. 505-512
-
-
Chinnaiyan, A.M.1
O'Rourke, K.2
Tewari, M.3
Dixit, V.M.4
-
13
-
-
0029905073
-
Molecular ordering of the Fas-apoptotic pathway: The Fas/APO-1 protease Mch5 is a CrmA-inhibitable protease that activates multiple Ced-3/ICE-like cysteine proteases
-
Srinivasula SM, Ahmad M, Fernandes-Alnemri T, Litwack G, Alnemri ES. Molecular ordering of the Fas-apoptotic pathway: the Fas/APO-1 protease Mch5 is a CrmA-inhibitable protease that activates multiple Ced-3/ICE-like cysteine proteases. Proc Natl Acad Sci USA 1996; 93: 14486-91.
-
(1996)
Proc. Natl. Acad. Sci. USA
, vol.93
, pp. 14486-14491
-
-
Srinivasula, S.M.1
Ahmad, M.2
Fernandes-Alnemri, T.3
Litwack, G.4
Alnemri, E.S.5
-
14
-
-
0028883850
-
Cytotoxicity-dependent Apo-1 (Fas/CD95) associated proteins form a death-inducing signalling complex (DISC) with the receptor
-
Kischkel FC, Hellbart S, Behrmann I, Germer M, Pawlita M, Krammer PH, Peter ME. Cytotoxicity-dependent Apo-1 (Fas/CD95) associated proteins form a death-inducing signalling complex (DISC) with the receptor. EMBO J 1995; 14: 5579-88.
-
(1995)
EMBO J.
, vol.14
, pp. 5579-5588
-
-
Kischkel, F.C.1
Hellbart, S.2
Behrmann, I.3
Germer, M.4
Pawlita, M.5
Krammer, P.H.6
Peter, M.E.7
-
15
-
-
0028913550
-
A novel protein that interacts with the death domain of Fas/APO1 contains a sequence motif related to the death domain
-
Boldin MP, Varfolomeev EE, Pancer Z, Mett IL, Camonis JH, Wallach D. A novel protein that interacts with the death domain of Fas/APO1 contains a sequence motif related to the death domain. J Biol Chem 1995; 270: 7795-8.
-
(1995)
J. Biol. Chem.
, vol.270
, pp. 7795-7798
-
-
Boldin, M.P.1
Varfolomeev, E.E.2
Pancer, Z.3
Mett, I.L.4
Camonis, J.H.5
Wallach, D.6
-
16
-
-
0030011398
-
Involvement of MACH, a novel MORT-1/FADD-interacting protease, in Fas/APO-1 and TNF receptor-induced cell death
-
Boldin MP, Goncharov TM, Golstev YV, Wallach D. Involvement of MACH, a novel MORT-1/FADD-interacting protease, in Fas/APO-1 and TNF receptor-induced cell death. Cell 1996; 85: 803-15.
-
(1996)
Cell
, vol.85
, pp. 803-815
-
-
Boldin, M.P.1
Goncharov, T.M.2
Golstev, Y.V.3
Wallach, D.4
-
17
-
-
15844412409
-
FLICE, a novel FADD-homologous ICE/CED-3-like protease, is recruited to the CD95 (Fas/APO-1) death-inducing signalling complex
-
Muzio M, Chnnaiyan AM, Kischkel FC, O'Rourke K, Shevchenko A, Ni J, Schaffid C, Bretz JD, Zhang M, Gentz R, Krammer PH, Peter ME, Dixit VM. FLICE, a novel FADD-homologous ICE/CED-3-like protease, is recruited to the CD95 (Fas/APO-1) death-inducing signalling complex. Cell 1996; 85: 817-27.
-
(1996)
Cell
, vol.85
, pp. 817-827
-
-
Muzio, M.1
Chnnaiyan, A.M.2
Kischkel, F.C.3
O'Rourke, K.4
Shevchenko, A.5
Ni, J.6
Schaffid, C.7
Bretz, J.D.8
Zhang, M.9
Gentz, R.10
Krammer, P.H.11
Peter, M.E.12
Dixit, V.M.13
-
18
-
-
0030925774
-
FLICE is activated by association with the CD95 death-inducing signalling complex (DISC)
-
Medema JP, Schaffid C, Kischkel FC, Shevchenko A, Mann M, Krammer PH, Peter ME. FLICE is activated by association with the CD95 death-inducing signalling complex (DISC). EMBO J 1997; 16: 2794-804.
-
(1997)
EMBO J.
, vol.16
, pp. 2794-2804
-
-
Medema, J.P.1
Schaffid, C.2
Kischkel, F.C.3
Shevchenko, A.4
Mann, M.5
Krammer, P.H.6
Peter, M.E.7
-
19
-
-
0032536771
-
Two CD95 (APO-1/Fas) signalling pathways
-
Scaffid C, Fulda S, Srinivasan A, Friesen C, Li F, Tomaselli KJ, Debatin KM, Krammer PH, Peter ME. Two CD95 (APO-1/Fas) signalling pathways. EMBO J 1998; 17: 1675-87.
-
(1998)
EMBO J.
, vol.17
, pp. 1675-1687
-
-
Scaffid, C.1
Fulda, S.2
Srinivasan, A.3
Friesen, C.4
Li, F.5
Tomaselli, K.J.6
Debatin, K.M.7
Krammer, P.H.8
Peter, M.E.9
-
20
-
-
0029075329
-
Tumor necrosis factor ligand superfamily involvement in pathology of malignant lymphoma
-
Gruss HJ, Dower S. Tumor necrosis factor ligand superfamily involvement in pathology of malignant lymphoma. Blood 1995; 85: 3378-404.
-
(1995)
Blood
, vol.85
, pp. 3378-3404
-
-
Gruss, H.J.1
Dower, S.2
-
21
-
-
0027145632
-
Molecular cloning and expression of the Fas ligand: A novel member of the tumor necrosis family
-
Suda T, Takahashi T, Golstein P, Nagata S. Molecular cloning and expression of the Fas ligand: a novel member of the tumor necrosis family. Cell 1993; 75: 1169-78.
-
(1993)
Cell
, vol.75
, pp. 1169-1178
-
-
Suda, T.1
Takahashi, T.2
Golstein, P.3
Nagata, S.4
-
22
-
-
0028919473
-
Expression of the functional soluble form of human Fas ligand in activated lymphocytes
-
Tanaka M, Suda T, Takahashi T, Nagata S. Expression of the functional soluble form of human Fas ligand in activated lymphocytes. EMBO J 1995; 14: 1129-35.
-
(1995)
EMBO J.
, vol.14
, pp. 1129-1135
-
-
Tanaka, M.1
Suda, T.2
Takahashi, T.3
Nagata, S.4
-
24
-
-
0032550366
-
Conversion of membrane-bound Fas (CD95) ligand to its soluble form is associated with downregulation of its proapoptotic activity and loss of liver toxicity
-
Schneider P, Holler N, Bodmer JL, Harne M, Frei K, Fontana A, Tshopp J. Conversion of membrane-bound Fas (CD95) ligand to its soluble form is associated with downregulation of its proapoptotic activity and loss of liver toxicity. J Exp Med 1998; 187: 1205-13.
-
(1998)
J. Exp. Med.
, vol.187
, pp. 1205-1213
-
-
Schneider, P.1
Holler, N.2
Bodmer, J.L.3
Harne, M.4
Frei, K.5
Fontana, A.6
Tshopp, J.7
-
25
-
-
0023037725
-
Phenotypic profile of human neuroblastoma cell lines: Association with morphological characteristics
-
Komada Y, Azuma E, Kamiya H, Sakurai M. Phenotypic profile of human neuroblastoma cell lines: association with morphological characteristics. Br J Cancer 1986; 54: 711-5.
-
(1986)
Br. J. Cancer
, vol.54
, pp. 711-7115
-
-
Komada, Y.1
Azuma, E.2
Kamiya, H.3
Sakurai, M.4
-
26
-
-
0030914282
-
Mitogen-activated protein kinase-mediated Fas apoptotic signaling pathway
-
Goillot E, Raingeaud J, Ranger A, Tepper RI, Davis RJ, Harlow E, Sanchez I. Mitogen-activated protein kinase-mediated Fas apoptotic signaling pathway. Proc Natl Acad Sci USA 1997; 94: 3302-7.
-
(1997)
Proc. Natl. Acad. Sci. USA
, vol.94
, pp. 3302-3307
-
-
Goillot, E.1
Raingeaud, J.2
Ranger, A.3
Tepper, R.I.4
Davis, R.J.5
Harlow, E.6
Sanchez, I.7
-
27
-
-
0022476194
-
Identical expression of cell surface membrane antigens on two parent and eighteen cloned cell lines derived from two different neuroblastoma metastases of the same patient
-
Sugimoto T, Sawada T, Matsumura T, Kemshead JT, Ishii T, Horii Y, Morioka H, Morita M, Reynolds CT. Identical expression of cell surface membrane antigens on two parent and eighteen cloned cell lines derived from two different neuroblastoma metastases of the same patient. Cancer Res 1986; 46: 4765-9.
-
(1986)
Cancer Res.
, vol.46
, pp. 4765-4769
-
-
Sugimoto, T.1
Sawada, T.2
Matsumura, T.3
Kemshead, J.T.4
Ishii, T.5
Horii, Y.6
Morioka, H.7
Morita, M.8
Reynolds, C.T.9
-
28
-
-
0025897621
-
Alpha-smooth-muscle actin and desmin expressions in human neuroblastoma cell lines
-
Sugimoto T, Ueyama H, Hosoi H, Inazawa J, Kato T, Kemshead JT, Reynolds CT, Gown AM, Mine H, Sawada T. Alpha-smooth-muscle actin and desmin expressions in human neuroblastoma cell lines. Int J Cancer 1991; 48: 277-83.
-
(1991)
Int. J. Cancer
, vol.48
, pp. 277-283
-
-
Sugimoto, T.1
Ueyama, H.2
Hosoi, H.3
Inazawa, J.4
Kato, T.5
Kemshead, J.T.6
Reynolds, C.T.7
Gown, A.M.8
Mine, H.9
Sawada, T.10
-
29
-
-
0028885701
-
Fas receptor (CD95)-mediated apoptosis is induced in leukemic cells entering G1B compartment of the cell cycle
-
Komada Y, Zhou YW, Zhang XL, Xue HL, Sakai H, Tanaka S, Sakatoku H, Sakurai M. Fas receptor (CD95)-mediated apoptosis is induced in leukemic cells entering G1B compartment of the cell cycle. Blood 1995; 86: 3848-60.
-
(1995)
Blood
, vol.86
, pp. 3848-3860
-
-
Komada, Y.1
Zhou, Y.W.2
Zhang, X.L.3
Xue, H.L.4
Sakai, H.5
Tanaka, S.6
Sakatoku, H.7
Sakurai, M.8
-
30
-
-
13344268993
-
Fas ligand in human serum
-
Tanaka M, Suda T, Haze K, Nakamura N, Sato K, Kimura F, Motoyoshi K, Mizuki M, Tagawa S, Ohga S, Hatake K, Drummond AH, Nagata S. Fas ligand in human serum. Nat Med 1996; 2: 317-22.
-
(1996)
Nat. Med.
, vol.2
, pp. 317-322
-
-
Tanaka, M.1
Suda, T.2
Haze, K.3
Nakamura, N.4
Sato, K.5
Kimura, F.6
Motoyoshi, K.7
Mizuki, M.8
Tagawa, S.9
Ohga, S.10
Hatake, K.11
Drummond, A.H.12
Nagata, S.13
-
31
-
-
0033590598
-
Structure and chromosome localization of the human CASP8 gene
-
Grenet J, Teitz T, Wei T, Valentine V, Kidd VJ. Structure and chromosome localization of the human CASP8 gene. Gene 1999; 226: 225-32.
-
(1999)
Gene
, vol.226
, pp. 225-232
-
-
Grenet, J.1
Teitz, T.2
Wei, T.3
Valentine, V.4
Kidd, V.J.5
-
32
-
-
0034066405
-
Caspase 8 is deleted or silenced preferentially in childhood neuroblastomas with amplification of MYCN
-
Teitz T, Wei T, Valentine MB, Vanin EF, Grenet J, Valentine VA, Behm, FG, Look AT, Lahti JM, Kidd VJ. Caspase 8 is deleted or silenced preferentially in childhood neuroblastomas with amplification of MYCN. Nat Med 2000; 6: 529-35.
-
(2000)
Nat. Med.
, vol.6
, pp. 529-535
-
-
Teitz, T.1
Wei, T.2
Valentine, M.B.3
Vanin, E.F.4
Grenet, J.5
Valentine, V.A.6
Behm, F.G.7
Look, A.T.8
Lahti, J.M.9
Kidd, V.J.10
-
33
-
-
0034662625
-
Loss of caspase-8 expression in highly malignant human neuroblastoma cells correlates with resistance to tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis
-
Hopkins-Donaldson S, Bodmer J, Bourloud KB, Brognara CB, Tschopp J, Gross N. Loss of caspase-8 expression in highly malignant human neuroblastoma cells correlates with resistance to tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis. Cancer Res 2000; 60: 4315-9.
-
(2000)
Cancer Res.
, vol.60
, pp. 4315-4319
-
-
Hopkins-Donaldson, S.1
Bodmer, J.2
Bourloud, K.B.3
Brognara, C.B.4
Tschopp, J.5
Gross, N.6
-
34
-
-
0035866396
-
Resistance to tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis in neuroblastoma cells correlates with a loss of caspase-8 expression
-
Eggert A, Grotzer MA, Zuzak TJ, Wiewrodt BR, Ho R, Ikegaki N, Brodeur GM. Resistance to tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis in neuroblastoma cells correlates with a loss of caspase-8 expression. Cancer Res 2001; 61: 1314-9.
-
(2001)
Cancer Res.
, vol.61
, pp. 1314-1319
-
-
Eggert, A.1
Grotzer, M.A.2
Zuzak, T.J.3
Wiewrodt, B.R.4
Ho, R.5
Ikegaki, N.6
Brodeur, G.M.7
-
35
-
-
0032753867
-
Requirement of cooperative functions of two repeated death effector domains in caspase 8 and in MC 159 for induction and inhibition of apoptosis respectively
-
Tsukumo S, Yonehara S. Requirement of cooperative functions of two repeated death effector domains in caspase 8 and in MC 159 for induction and inhibition of apoptosis respectively. Genes Cells 1999; 4: 541-9.
-
(1999)
Genes Cells
, vol.4
, pp. 541-549
-
-
Tsukumo, S.1
Yonehara, S.2
|